Stressed Mice Exhibit PTSD-Like Aversion: Insights into Memory and Generalized Fear Responses
Scientists at the Hospital for Sick Children (SickKids) studied how stress affects memory. Led by Sheena Josselyn, PhD, and Paul Frankland, PhD, the team researched how stress changes how the brain encodes and retrieves negative memories. They found that endocannabinoid (eCB) signaling plays a crucial role in this process. Their findings could lead to new treatments for post-traumatic stress disorder (PTSD).
“Some stress is helpful, but too much can be harmful,” Josselyn explained. People with PTSD often react fearfully to safe situations. The research aims to limit these fears and reduce PTSD’s negative effects.
During experiments, mice were trained to associate specific sounds with stress or safety. Stressed mice showed defensive behavior to both sounds, indicating that stress disrupted their ability to form distinct memories. In contrast, non-stressed mice only reacted defensively to the sound linked to stress.
The researchers measured high levels of corticosterone (CORT) in the stressed mice, which affected memory formation. Mice given CORT before training also had trouble forming distinct memories. When the researchers used metyrapone, a drug that reduces glucocorticoid levels, stressed mice could form specific memories again.
Memories are stored in groups of neurons called engrams. The study showed that stressed mice had larger engrams, as inhibitory interneurons failed to restrict their size. This size increase was linked to excessive eCB release in the amygdala, the brain’s emotional center. eCBs help link experiences with memories. Normally, certain interneurons with eCB receptors regulate engram size, but stress disrupts this function.
What role does endocannabinoid signaling play in the relationship between stress and memory processing?
Interview with Dr. Sheena Josselyn and Dr. Paul Frankland on the Impact of Stress on Memory and Potential PTSD Treatments
By [Your Name], News Editor – newsdirectory3.com
In a groundbreaking study conducted at the Hospital for Sick Children (SickKids), researchers have delved into the intricate relationship between stress and memory, shedding light on vital mechanisms that may pave the way for innovative treatments for post-traumatic stress disorder (PTSD). We had the privilege of speaking with Dr. Sheena Josselyn and Dr. Paul Frankland, the lead researchers of the study, to gain deeper insights into their findings and the implications for PTSD treatment.
News Directory 3: Thank you for joining us, Dr. Josselyn and Dr. Frankland. Can you start by explaining the core finding of your study about how stress affects memory?
Dr. Josselyn: Certainly. Our research focused on the impact of stress on how the brain encodes and retrieves memories, particularly negative ones. We discovered that endocannabinoid (eCB) signaling plays a pivotal role in this process. Essentially, while some stress can enhance memory and help us recall events for survival, excessive stress can create a hindrance, leading to maladaptive responses — like those observed in individuals with PTSD.
Dr. Frankland: To put it simply, our findings indicate that under significant stress, the brain’s capacity to process memories becomes compromised. Instead of allowing a person to differentiate between safe and unsafe situations, it can lead to generalized fear responses, making every similar situation feel threatening.
News Directory 3: That’s fascinating, especially the mention of endocannabinoid signaling. How does this signaling process specifically contribute to memory changes during stress?
Dr. Frankland: The endocannabinoid system is involved in regulating various physiological processes, including mood, memory, and pain perception. Our study suggests that during stress, eCB signaling alters how memories are formed and recalled. This alteration seems to disengage normal memory functions, leading to heightened anxiety and fear responses related to previously non-threatening stimuli.
News Directory 3: In your experiments, you trained mice to associate sounds with either stress or safety. Can you share your observations and what they might mean in the context of human PTSD?
Dr. Josselyn: Yes, during our trials, we noticed that mice subjected to stress exhibited defensive behaviors towards both the stress-associated sounds and neutral sounds. This was striking because it mirrors how individuals with PTSD often react fearfully to safe situations, unable to distinguish between what is genuinely threatening and what is not.
Dr. Frankland: These observations suggest that the encoding of memories, particularly negative ones, can become confused under prolonged stress. By understanding this mechanism, we can potentially find ways to mitigate these responses or recalibrate memory processing in those suffering from PTSD.
News Directory 3: It’s intriguing to think about the implications for treatment. What kind of future treatments do you envision based on your findings?
Dr. Josselyn: Our findings may lead to targeted therapies that enhance endocannabinoid signaling or modulate the brain’s response to stress. This could help recalibrate how individuals with PTSD process memories, ideally reducing their fear responses over time.
Dr. Frankland: We are also exploring compounds that can either enhance or mimic eCB signaling. This can lead to pharmacological treatments that might assist patients in distinguishing safe situations from those that induce stress, ultimately helping them navigate their daily lives more effectively.
News Directory 3: That certainly sounds promising for PTSD treatment. What steps will you take next in your research?
Dr. Josselyn: We plan to continue our studies using animal models to further dissect the eCB system’s functions in memory processes. We hope to develop potential therapies that could eventually progress to clinical trials.
Dr. Frankland: Collaboration with clinical psychologists and psychiatrists will be critical as we translate our findings into practical applications for humans. We believe that with a more profound understanding of these mechanisms, we can create effective treatment pathways.
News Directory 3: Thank you again, Dr. Josselyn and Dr. Frankland, for sharing your exciting research with us. We look forward to seeing how these findings evolve and the potential impact they may have on individuals affected by PTSD.
Dr. Josselyn & Dr. Frankland: Thank you for having us and for your interest in our work!
This interview highlights the critical intersection of stress, memory, and the potential for advancing PTSD treatments through scientific research. Stay tuned for further developments in this important area of study.
Matthew Hill, PhD, noted that manipulating eCB receptors in a specific brain region restored memory specificity. This could provide a path for therapies for humans.
Josselyn compared eCB receptors to a velvet rope at a club. When stress releases too many eCBs, the rope “falls,” leading to generalized fearful memories. Blocking eCB receptors could help mitigate PTSD symptoms.
The study reinforces the impact of eCBs in the amygdala regarding stress and memories. The researchers aim to understand how stress influences both negative and positive memories in the future, including the implications of cannabinoids like cannabis on memory specificity. They also want to investigate if daily stressors can affect positive memories.
Frankland highlighted that learning more about memory could lead to real-world therapies for various brain disorders. The researchers continue to explore the connections between stress, engram size, and memory throughout life.